If you take a look through our entire range of benzodiazepines, you will probably notice that at Research Chemistry we are committed to supplying a wide variety of these chemical products. As a part of this, we stock Pyrazolam – this is a benzodiazepine that was originally developed during the 1970s. Leo Sternbach was the most famous member of the team responsible for its development, and at Research Chemistry we are pleased to be able to continue this pioneering research. Unlike other similar compounds that display a wide range of behaviours during experiments, Pyrazolam leads to mainly anxiolytic results during investigations – these are roughly 12 times stronger than those same reactions using Diazepam.
The way in which Pyrazolam metabolizes sets it apart from a number of other benzodiazepines – it appears to be entirely resistant to the metabolic process. As a result, experiments often result in a waste product that contains no metabolites that have originated from the initial experiment. Its full chemical name is 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine, and it has a half-life that puts at in the middle of the range shown by other benzodiazepines – approximately 17 hours.
Pyrazolam has been available as a research chemical since 2012, and we initially noticed that in terms of its molecular structure, it is very similar to Alprazolam. Ataxia and sedation-like chemical observations are kept to an absolute minimum when experimenting with Pyrazolam within lower concentrations, and we offer pellets of differing 0.5mg & 1mg values for your convenience.